Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mark D. Hauge"'
Autor:
Kendrith M. Rowland, Patrick J. Flynn, Mark D. Hauge, Nathan R. Foster, Dennis F. Moore, Philip J. Stella, Aminah Jatoi, Steven R. Alberts, Shaker R. Dakhil, Anthony J. Jaslowski, Sachdev P. Thomas, Cynthia X. Ma
Publikováno v:
Journal of Thoracic Oncology. 3:516-520
Purpose This study was undertaken to explore the response rate of a first-line, three-drug regimen that consisted of bortezomib, paclitaxel, and carboplatin in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, or ga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae717c2071f64061adb857063fbaa9b
https://doi.org/10.1097/jto.0b013e31816de276
https://doi.org/10.1097/jto.0b013e31816de276
Autor:
Revathi Swaminathan, Mark D. Hauge, Philip J. Stella, Richard Charles Tenglin, Nathan R. Foster, Michael G. Haddock, John K. Camoriano, Dennis F. Moore, James A. Martenson, Paul L. Schaefer, Steven R. Alberts
Publikováno v:
Journal of Clinical Oncology. 25:2567-2572
Purpose A phase II study was conducted to determine the efficacy and toxicity of radiotherapy with concomitant gemcitabine and cisplatin for patients with locally advanced pancreatic adenocarcinoma. Patients and Methods Forty-eight patients with loca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90e59f1b562cc53ac10dde84ecae780d
https://doi.org/10.1200/jco.2006.10.2111
https://doi.org/10.1200/jco.2006.10.2111
Autor:
Mark D. Hauge, John Q. Su, Harry J. Long, Maurice J. Webb, Lynn C. Hartmann, John H. Edmonson
Publikováno v:
Investigational new drugs. 10(4)
A Phase II trial of an intravenous preparation of Hexamethylmelamine was performed in ovarian cancer. Patients who had received prior Platinum based chemotherapy and had measurable disease were eligible. Among 15 evaluable patients, there were no obj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8859ad0954ccab66e3a2263cc8b0bf88
https://pubmed.ncbi.nlm.nih.gov/1487403
https://pubmed.ncbi.nlm.nih.gov/1487403
Autor:
Harry J. Long, Stephen Frytak, Mark D. Hauge, Jan C. Buckner, Richard G. Hahn, Terry M. Therneau
Publikováno v:
Investigational new drugs. 9(3)
Fifteen patients with advanced renal cell carcinoma were treated with Menogaril, 200 mg/m2 by one-hour, intravenous infusion at four-week intervals. No objective regressions were observed. Median time to progression was two months, and median surviva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d91920ad1c97733a1e3af933cf047359
https://pubmed.ncbi.nlm.nih.gov/1838363
https://pubmed.ncbi.nlm.nih.gov/1838363
Autor:
Mark D. Hauge, Revathi Swaminathan, Nathan R. Foster, Steven R. Alberts, Richard M. Goldberg, James A. Martenson, Michael G. Haddock
Publikováno v:
Journal of Clinical Oncology. 22:4121-4121
4121 Background: In vitro studies suggest that low dose GEM sensitizes cells to RT for 48 hours following exposure. CIS is a radiation sensitizer and may result in synergistic cytotoxicity when combined with GEM. This phase II study was conducted to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4c93ffe797690614ea5f1ad63c452db
https://doi.org/10.1200/jco.2004.22.90140.4121
https://doi.org/10.1200/jco.2004.22.90140.4121
Publikováno v:
Mayo Clinic proceedings. 63(8)
Insufficiency fractures of the pelvis, which almost always occur in elderly women with osteoporosis, are often misinterpreted as metastatic disease. The initial symptom of such fractures is severe pain unassociated with an obvious history of trauma.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6559a9e4775c63e2fe2910786181677a
https://pubmed.ncbi.nlm.nih.gov/3398597
https://pubmed.ncbi.nlm.nih.gov/3398597